5 Segment information
Aegon’s operating segments are based on the businesses as presented in internal reports that are regularly reviewed by the Executive Board which is regarded as the chief operating decision maker. All reportable segments are involved in insurance or reinsurance business, asset management or services related to these activities. The reportable segments are:
◆ | Americas: one operating segment which covers business units in the United States, Brazil and Mexico, including any of the units’ activities located outside these countries; |
◆ | the Netherlands; |
◆ | United Kingdom (including Variable Annuities Europe); |
◆ | Central & Eastern Europe; |
◆ | Spain & Portugal; |
◆ | Asia: one operating segment which covers businesses operating in Hong Kong, Singapore, China, Japan, India and Indonesia including any of the units’ activities located outside these countries; |
◆ | Asset Management: one operating segment which covers business activities from Aegon Asset Management; |
◆ | Holding and other activities: one operating segment which includes financing, reinsurance activities, employee and other administrative expenses of holding companies. |
Aegon’s segment information is prepared by consolidating on a proportionate basis Aegon’s joint ventures and associated companies.
Performance Measure
A non-IFRS performance measure of reporting segments utilized by the Company is underlying earnings before tax. Underlying earnings before tax reflects Aegon’s profit from underlying business operations and excludes components that relate to accounting mismatches that are dependent on market volatility, updates to best estimate actuarial and economic assumptions and model updates or events that are considered outside the normal course of business.
Aegon believes that its performance measure underlying earnings before tax provides meaningful information about the underlying results of Aegon’s business, including insight into the financial measures that Aegon’s senior management uses in managing the business. Among other things, Aegon’s senior management is compensated based in part on Aegon’s results against targets using underlying earnings before tax. While many other insurers in Aegon’s peer group present substantially similar performance measures, the performance measures presented in this document may nevertheless differ from the performance measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards.
The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the tables in this note.
The items that are excluded from underlying earnings before tax as described further below are: fair value items, realized gains or losses on investments, impairment charges/reversals, other income or charges, run-off businesses and share in earnings of joint ventures and associates.
Impact from assumption and model updates
In 2017 a charge of EUR 276 million (2016: EUR 118 million charge) has been recorded in other income/ (charges) in respect of assumption changes and model updates. The impact is mainly attributable to Aegon’s business in the Americas and the Netherlands. Assumption changes and model updates in the Americas led to a net negative impact of EUR 402 million and were mainly driven by a charge of EUR 303 million (USD 343 million) from the conversion of the largest block of universal life business to a new model. The model allows for modeling policyholder behavior and other assumptions on a policy by policy basis, whereas in the previous model this was done at a cohort level. A model change in fixed annuities discount rate, resulted in a charge of EUR 44 million (USD 50 million) and other assumption changes and model updates led to a charge of EUR 54 million (USD 61 million). In the Netherlands, assumption changes and model updates led to a gain of EUR 101 million, which mainly relates to the guarantee provision.
During 2016 Aegon implemented actuarial assumption and model updates resulting in a net EUR 118 million charge (2015: EUR 131 million charge) to income before tax.
Fair value items
Fair value items include the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings before tax.
In addition, hedge ineffectiveness on hedge transactions, fair value changes on economic hedges without natural offset in earnings and for which no hedge accounting is applied and fair value movements on real estate are included under fair value items.
Certain assets held by Aegon are carried at fair value and managed on a total return basis, with no offsetting changes in the valuation of related liabilities. These include assets such as investments in hedge funds, private equities, real estate (limited partnerships), convertible bonds and structured products. Underlying earnings before tax exclude any over- or underperformance compared to management’s long-term expected return on assets. Based on current holdings and asset returns, the long-term expected return on an annual basis is 8-10%, depending on asset class, including cash income and market value changes. The expected earnings from these asset classes are net of deferred policy acquisition costs (DPAC) where applicable.
In addition, certain products offered by Aegon Americas contain guarantees and are reported on a fair value basis and the total return annuities and guarantees on variable annuities. The earnings on these products are impacted by movements in equity markets and risk-free interest rates. Short-term developments in the financial markets may therefore cause volatility in earnings. Included in underlying earnings before tax is a long-term expected return on these products and excluded is any over- or underperformance compared to management’s expected return.
The fair value movements of certain guarantees and the fair value change of derivatives that hedge certain risks on these guarantees of Aegon’s businesses in the Netherlands, VA Europe (included in United Kingdom) and Japan are excluded from underlying earnings before tax, and the long-term expected return for these guarantees is set at zero. In addition, fair value items include market related results on our loyalty bonus reserves in the United Kingdom. The value of these reserves are directly related to policyholder investments which value is directly impacted by movements in equity and bond markets.
Holding and other activities include certain issued bonds that are held at fair value through profit or loss (FVTPL). The interest rate risk on these bonds is hedged using swaps. The fair value movement resulting from changes in Aegon’s credit spread used in the valuation of these bonds are excluded from underlying earnings before tax and reported under fair value items.
Realized gains or losses on investments
Includes realized gains and losses on available-for-sale investments, mortgage loans and other loan portfolios.
Impairment charges/reversals
Impairment charges include impairments on available-for-sale debt securities, shares including the effect of deferred policyholder acquisition costs, mortgage loans and other loan portfolios at amortized cost, joint ventures and associates. Impairment reversals include reversals on available-for-sale debt securities.
Other income or charges
Other income or charges includes the following:
◆ | items which cannot be directly allocated to a specific line of business; |
◆ | the impact of assumption and model updates used to support calculations of our liabilities for insurance and investment contracts sold to policyholders and related assets; and |
◆ | items that are outside the normal course of business, including restructuring charges. |
In the Consolidated income statement, these restructuring charges are included in operating expenses. Actuarial assumption and model updates are recorded in ‘Policyholder claims and benefits’ in the Consolidated income statement.
Run-off businesses
Includes underlying results of business units where management has decided to exit the market and to run -off the existing block of business. This line includes results related to the run-off of the institutional spread-based business, structured settlements blocks of business, the life reinsurance business and the bank-owned and corporate-owned life insurance (BOLI/COLI) business in the United States. Aegon has other blocks of business for which sales have been discontinued and of which the earnings are included in underlying earnings before tax.
Share in earnings of joint ventures and associates
Earnings from Aegon’s joint ventures in the Netherlands, Mexico, Spain, Portugal, China and Japan and Aegon’s associates in India, Brazil, the Netherlands, United Kingdom, Mexico and France are reported on an underlying earnings before tax basis.
The following table presents Aegon’s segment results.
Income statement - Underlying earnings |
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
||||||||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||||||||||
Underlying earnings before tax |
1,381 | 520 | 116 | 67 | 4 | 49 | 136 | (170 | ) | - | 2,103 | 61 | 2,163 | |||||||||||||||||||||||||||||||||||
Fair value items |
170 | 30 | (82 | ) | - | - | - | - | 24 | - | 142 | (97 | ) | 45 | ||||||||||||||||||||||||||||||||||
Realized gains / (losses) on investments |
157 | 184 | 62 | 1 | - | 4 | 3 | - | - | 413 | (5 | ) | 408 | |||||||||||||||||||||||||||||||||||
Impairment charges |
(38 | ) | (27 | ) | - | (2 | ) | - | (1 | ) | - | (3 | ) | - | (71 | ) | - | (71 | ) | |||||||||||||||||||||||||||||
Impairment reversals |
22 | 10 | - | - | - | - | - | - | - | 32 | - | 32 | ||||||||||||||||||||||||||||||||||||
Other income / (charges) |
(353 | ) | 296 | 40 | - | - | (19 | ) | (49 | ) | 16 | - | (68 | ) | (4 | ) | (72 | ) | ||||||||||||||||||||||||||||||
Run-off businesses |
30 | - | - | - | - | - | - | - | - | 30 | - | 30 | ||||||||||||||||||||||||||||||||||||
Income / (loss) before tax |
1,369 | 1,013 | 137 | 66 | 4 | 33 | 90 | (134 | ) | - | 2,579 | (44 | ) | 2,534 | ||||||||||||||||||||||||||||||||||
Income tax (expense) / benefit |
198 | (196 | ) | (56 | ) | (9 | ) | (6 | ) | (28 | ) | (42 | ) | 29 | - | (110 | ) | 44 | (65 | ) | ||||||||||||||||||||||||||||
Net income / (loss) |
1,567 | 818 | 81 | 57 | (2 | ) | 5 | 48 | (105 | ) | - | 2,469 | - | 2,469 | ||||||||||||||||||||||||||||||||||
Inter-segment underlying earnings |
(78 | ) | (111 | ) | (87 | ) | (11 | ) | (1 | ) | (1 | ) | 214 | 73 | ||||||||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
7,437 | 1,857 | 9,603 | 411 | 208 | 983 | - | 7 | (9 | ) | 20,498 | (546 | ) | 19,952 | ||||||||||||||||||||||||||||||||||
Accident and health insurance |
2,115 | 203 | 32 | 1 | 83 | 97 | - | - | - | 2,531 | (20 | ) | 2,511 | |||||||||||||||||||||||||||||||||||
General insurance |
- | 148 | - | 216 | 103 | - | - | 1 | (1 | ) | 466 | (103 | ) | 363 | ||||||||||||||||||||||||||||||||||
Total gross premiums |
9,553 | 2,208 | 9,635 | 628 | 394 | 1,080 | - | 8 | (10 | ) | 23,496 | (670 | ) | 22,826 | ||||||||||||||||||||||||||||||||||
Investment income |
3,368 | 2,172 | 1,517 | 49 | 37 | 246 | 4 | 295 | (291 | ) | 7,396 | (58 | ) | 7,338 | ||||||||||||||||||||||||||||||||||
Fee and commission income |
1,919 | 326 | 235 | 43 | 17 | 63 | 609 | - | (221 | ) | 2,991 | (189 | ) | 2,802 | ||||||||||||||||||||||||||||||||||
Other revenues |
5 | - | - | - | 3 | 1 | - | 4 | - | 13 | (5 | ) | 7 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,844 | 4,706 | 11,387 | 720 | 450 | 1,390 | 613 | 308 | (522 | ) | 33,895 | (922 | ) | 32,973 | ||||||||||||||||||||||||||||||||||
Inter-segment revenues |
- | (1 | ) | - | - | - | 3 | 222 | 298 |
Income statement - Underlying earnings |
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
||||||||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||||||||||
Underlying earnings before tax |
1,249 | 534 | 59 | 55 | 8 | 21 | 149 | (162 | ) | - | 1,913 | 48 | 1,960 | |||||||||||||||||||||||||||||||||||
Fair value items |
(521 | ) | (228 | ) | (7 | ) | - | (1 | ) | (9 | ) | - | (74 | ) | - | (840 | ) | (72 | ) | (912 | ) | |||||||||||||||||||||||||||
Realized gains / (losses) on investments |
(13 | ) | 189 | 153 | - | (1 | ) | 8 | 3 | - | - | 340 | (6 | ) | 334 | |||||||||||||||||||||||||||||||||
Impairment charges |
(72 | ) | (29 | ) | - | 1 | - | (1 | ) | (5 | ) | (7 | ) | 1 | (113 | ) | - | (112 | ) | |||||||||||||||||||||||||||||
Impairment reversals |
42 | 17 | - | - | - | - | - | - | (1 | ) | 58 | - | 58 | |||||||||||||||||||||||||||||||||||
Other income / (charges) |
(100 | ) | 44 | (678 | ) | (23 | ) | - | (5 | ) | (2 | ) | (6 | ) | - | (771 | ) | - | (771 | ) | ||||||||||||||||||||||||||||
Run-off businesses |
54 | - | - | - | - | - | - | - | - | 54 | - | 54 | ||||||||||||||||||||||||||||||||||||
Income / (loss) before tax |
638 | 526 | (474 | ) | 34 | 6 | 14 | 145 | (249 | ) | - | 641 | (31 | ) | 610 | |||||||||||||||||||||||||||||||||
Income tax (expense) / benefit |
(80 | ) | (109 | ) | 18 | (15 | ) | (8 | ) | (27 | ) | (48 | ) | 65 | - | (203 | ) | 31 | (172 | ) | ||||||||||||||||||||||||||||
Net income / (loss) |
559 | 418 | (456 | ) | 19 | (2 | ) | (13 | ) | 97 | (183 | ) | - | 438 | - | 438 | ||||||||||||||||||||||||||||||||
Inter-segment underlying earnings |
(194 | ) | (95 | ) | (87 | ) | (14 | ) | (1 | ) | 74 | 234 | 84 | |||||||||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
7,363 | 2,015 | 9,888 | 399 | 191 | 1,121 | - | 6 | (84 | ) | 20,898 | (498 | ) | 20,400 | ||||||||||||||||||||||||||||||||||
Accident and health insurance |
2,204 | 210 | 36 | 1 | 73 | 104 | - | (4 | ) | - | 2,624 | (15 | ) | 2,609 | ||||||||||||||||||||||||||||||||||
General insurance |
- | 266 | - | 179 | 92 | - | - | 5 | (5 | ) | 536 | (92 | ) | 444 | ||||||||||||||||||||||||||||||||||
Total gross premiums |
9,567 | 2,491 | 9,924 | 578 | 355 | 1,225 | - | 7 | (89 | ) | 24,058 | (606 | ) | 23,453 | ||||||||||||||||||||||||||||||||||
Investment income |
3,717 | 2,135 | 1,661 | 45 | 45 | 232 | 3 | 406 | (403 | ) | 7,841 | (54 | ) | 7,788 | ||||||||||||||||||||||||||||||||||
Fee and commission income |
1,651 | 350 | 95 | 36 | 14 | 61 | 632 | - | (242 | ) | 2,596 | (188 | ) | 2,408 | ||||||||||||||||||||||||||||||||||
Other revenues |
4 | - | - | - | 2 | - | 1 | 3 | - | 11 | (4 | ) | 7 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,940 | 4,976 | 11,680 | 659 | 416 | 1,517 | 636 | 416 | (734 | ) | 34,507 | (852 | ) | 33,655 | ||||||||||||||||||||||||||||||||||
Inter-segment revenues |
- | 3 | - | - | - | 79 | 243 | 409 |
Income statement - Underlying earnings |
LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | ||||||||||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||||||||||
Underlying earnings before tax |
1,278 | 537 | (27 | ) | 37 | 12 | 20 | 170 | (163 | ) | 2 | 1,867 | 34 | 1,901 | ||||||||||||||||||||||||||||||||||
Fair value items |
(691 | ) | 126 | (25 | ) | - | - | 7 | - | (68 | ) | - | (651 | ) | (59 | ) | (710 | ) | ||||||||||||||||||||||||||||||
Realized gains / (losses) on investments |
(74 | ) | 306 | 103 | 2 | - | 7 | 3 | - | - | 346 | (8 | ) | 338 | ||||||||||||||||||||||||||||||||||
Impairment charges |
(43 | ) | (25 | ) | - | (2 | ) | - | - | - | - | - | (70 | ) | (21 | ) | (91 | ) | ||||||||||||||||||||||||||||||
Impairment reversals |
114 | 5 | - | - | - | - | - | - | - | 119 | - | 119 | ||||||||||||||||||||||||||||||||||||
Other income / (charges) |
(913 | ) | 27 | (1,247 | ) | (2 | ) | 17 | (61 | ) | (1 | ) | - | - | (2,180 | ) | 21 | (2,159 | ) | |||||||||||||||||||||||||||||
Run-off businesses |
88 | - | - | - | - | - | - | - | - | 88 | - | 88 | ||||||||||||||||||||||||||||||||||||
Income / (loss) before tax |
(241 | ) | 977 | (1,196 | ) | 35 | 29 | (27 | ) | 172 | (230 | ) | 2 | (482 | ) | (33 | ) | (514 | ) | |||||||||||||||||||||||||||||
Income tax (expense) / benefit |
6 | (223 | ) | 268 | (11 | ) | (7 | ) | (3 | ) | (50 | ) | 71 | - | 51 | 33 | 83 | |||||||||||||||||||||||||||||||
Net income / (loss) |
(235 | ) | 753 | (928 | ) | 24 | 22 | (30 | ) | 121 | (159 | ) | 2 | (431 | ) | - | (431 | ) | ||||||||||||||||||||||||||||||
Inter-segment underlying earnings |
(220 | ) | (55 | ) | (63 | ) | (14 | ) | - | 77 | 264 | 10 | ||||||||||||||||||||||||||||||||||||
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||||||||||
Life insurance gross premiums |
7,046 | 2,240 | 8,465 | 477 | 174 | 1,713 | - | 4 | (106 | ) | 20,013 | (431 | ) | 19,583 | ||||||||||||||||||||||||||||||||||
Accident and health insurance |
2,266 | 234 | 47 | 1 | 64 | 105 | - | 6 | (6 | ) | 2,717 | (14 | ) | 2,703 | ||||||||||||||||||||||||||||||||||
General insurance |
- | 473 | - | 164 | 80 | - | - | 2 | - | 720 | (80 | ) | 640 | |||||||||||||||||||||||||||||||||||
Total gross premiums |
9,312 | 2,947 | 8,512 | 642 | 317 | 1,819 | - | 13 | (112 | ) | 23,450 | (524 | ) | 22,925 | ||||||||||||||||||||||||||||||||||
Investment income |
3,680 | 2,277 | 2,331 | 45 | 41 | 194 | 7 | 392 | (391 | ) | 8,576 | (51 | ) | 8,525 | ||||||||||||||||||||||||||||||||||
Fee and commission income |
1,704 | 351 | 98 | 39 | 13 | 62 | 650 | - | (284 | ) | 2,633 | (195 | ) | 2,438 | ||||||||||||||||||||||||||||||||||
Other revenues |
9 | - | - | - | 2 | - | - | 7 | - | 19 | (5 | ) | 14 | |||||||||||||||||||||||||||||||||||
Total revenues |
14,705 | 5,575 | 10,941 | 726 | 373 | 2,076 | 657 | 412 | (787 | ) | 34,677 | (775 | ) | 33,902 | ||||||||||||||||||||||||||||||||||
Inter-segment revenues |
24 | 2 | - | - | - | 101 | 261 | 399 |
The Group uses underlying earnings before tax in its segment reporting as an important indicator of its financial performance. The reconciliation of this measure to the income before tax is shown below. Aegon believes that underlying earnings before tax, together with the other information included in this report, provides a meaningful measure for the investing public to evaluate Aegon’s business relative to the businesses of its peers.
The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the table below. For those items that cannot be directly reconciled to the respective notes, the explanation is provided below the table.
Note | 2017 | 2016 | 2015 | |||||||||||||
Underlying earnings before tax |
2,103 | 1,913 | 1,867 | |||||||||||||
Elimination of share in earnings of joint ventures and associates |
61 | 48 | 34 | |||||||||||||
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives |
10 | (437 | ) | (783 | ) | (571 | ) | |||||||||
Realized gains and losses on financial investments |
10 | 431 | 327 | 349 | ||||||||||||
Gains and (losses) on investments in real estate |
10 | 193 | 70 | 145 | ||||||||||||
Net fair value change of derivatives |
10 | (134 | ) | (277 | ) | (29 | ) | |||||||||
Net foreign currency gains and (losses) |
10 | 5 | 30 | (5 | ) | |||||||||||
Realized gains and (losses) on repurchased debt |
10 | 1 | 1 | 2 | ||||||||||||
Other income |
11 | 540 | 66 | 83 | ||||||||||||
Change in valuation of liabilities for insurance contracts |
12 | (254 | ) | (144 | ) | (602 | ) | |||||||||
Change in valuation of liabilities for investment contracts |
12 | (19 | ) | (18 | ) | - | ||||||||||
Policyholder claims and benefits - Other |
12 | 34 | 45 | 17 | ||||||||||||
Commissions and expenses |
14 | 256 | 75 | 130 | ||||||||||||
Impairment (charges) reversals |
15 | (40 | ) | (97 | ) | (1,250 | ) | |||||||||
Other charges |
17 | (235 | ) | (700 | ) | (774 | ) | |||||||||
Run-off businesses |
5 | 30 | 54 | 88 | ||||||||||||
Income / (loss) before tax |
2,534 | 610 | (514 | ) |
◆ | Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives is reported as part of the respective line in Note 10 and reflects the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings before tax. |
◆ | Net fair value change of derivatives is reported as part of the respective line in Note 10 and includes: 1) the over- or underperformance of derivatives of EUR 9 million gain (2016: EUR 8 million gain, 2015: EUR 4 million gain) for which the expected long-term return is included in underlying earnings before tax; 2) Net fair value change on economic hedges where no hedge accounting is applied of EUR 145 million loss (2016: EUR 297 million loss, 2015: EUR 41 million loss); 3) Ineffective portion of hedge transactions to which hedge accounting is applied of EUR 2 million gain (2016: EUR 12 million gain, 2015: EUR 8 million gain). |
◆ | Net foreign currency gains and (losses) are reported as part of the respective line in Note 10. |
◆ | Change in valuation of liabilities for insurance contracts is reported as part of the respective line in Note 12. |
◆ | Change in valuation of liabilities for investment contracts is reported as part of the respective line in Note 12. |
◆ | Policyholder claims and benefits - Other are reported as part of the “Other” line in note 12 and is related to policyholder tax. |
◆ | Commissions and expenses include: 1) Restructuring charges of EUR 116 million (2016: EUR 54 million charge, 2015: EUR 59 million charge) which are reported as part of Employee and Administration expenses lines in Note 14; 2) Amortization of deferred expenses of EUR 285 million gain (2016: gain of EUR 137 million, 2015: gain of EUR 126 million) which is reported as part of the respective line in Note 14. This is offset against realized gains and losses and impairments on financial investments; 3) Amortization of VOBA and future servicing rights of EUR 94 million gain (2016: charge of EUR 8 million; 2015: gain of EUR 63 million) which is reported as part of the respective line in Note 14. Commissions and expenses include a DPAC/VOBA fair value adjustment of EUR 135 million (2016: EUR 105 million; 2015: EUR 41 million). |
◆ | Impairment (charges) reversals include: 1) Impairment charges and reversals on financial assets, excluding receivables of EUR 42 million charge (2016: EUR 59 million charge, 2015: EUR 24 million gain) as shown in Note 15; 2) Impairment charges and reversals on non-financial assets and receivables of EUR 1 million gain (2016: EUR 38 million charge; 2015: EUR 1,274 million charge) reported as part of the respective line in Note 15. |
◆ | There are no interest charges and related fees that are classified for segment reporting purposes as non-underlying earnings. |
Other selected income statement items |
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Amortization of deferred expenses, VOBA and future servicing rights |
336 | 27 | 134 | 55 | - | 33 | - | - | - | 586 | ||||||||||||||||||||||||||||||
Depreciation |
44 | 16 | 28 | 8 | 3 | 1 | 3 | 2 | - | 105 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on financial assets, excluding receivables |
19 | 17 | - | 2 | - | - | - | 3 | - | 42 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
(2 | ) | 3 | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Amortization of deferred expenses, VOBA and future servicing rights |
761 | 32 | 177 | 59 | - | 32 | - | - | 2 | 1,065 | ||||||||||||||||||||||||||||||
Depreciation |
38 | 17 | 21 | 9 | 3 | 1 | - | 2 | - | 89 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on financial assets, excluding receivables |
35 | 12 | - | (1 | ) | - | 1 | 5 | 7 | - | 59 | |||||||||||||||||||||||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
7 | (2 | ) | 31 | (1 | ) | - | - | - | - | - | 36 | ||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||
Amortization of deferred expenses, VOBA and future servicing rights |
731 | 39 | 377 | 80 | - | 34 | - | - | - | 1,261 | ||||||||||||||||||||||||||||||
Depreciation |
31 | 17 | 23 | 9 | 2 | 1 | - | - | - | 84 | ||||||||||||||||||||||||||||||
Impairment charges / (reversals) on financial assets, excluding receivables |
(68 | ) | 20 | - | 2 | 21 | - | - | - | - | (24 | ) | ||||||||||||||||||||||||||||
Impairment charges / (reversals) on non-financial assets and receivables |
- | 2 | 1,274 | - | - | - | - | - | - | 1,275 | ||||||||||||||||||||||||||||||
Number of employees | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | |||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Number of employees - headcount |
10,951 | 3,089 | 3,435 | 2,337 | 610 | 6,025 | 1,500 | 371 | 28,318 | |||||||||||||||||||||||||||||||
Of which Aegon’s share of employees in joint ventures and associates |
549 | - | - | - | 83 | 5,702 | 163 | - | 6,497 | |||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Number of employees - headcount |
11,943 | 4,464 | 2,673 | 2,317 | 600 | 5,579 | 1,474 | 330 | 29,380 | |||||||||||||||||||||||||||||||
Of which Aegon’s share of employees in joint ventures and associates |
561 | - | - | - | 41 | 5,186 | 156 | - | 5,944 | |||||||||||||||||||||||||||||||
2015 |
||||||||||||||||||||||||||||||||||||||||
Number of employees - headcount |
12,701 | 4,503 | 2,478 | 2,470 | 534 | 7,163 | 1,382 | 299 | 31,530 | |||||||||||||||||||||||||||||||
Of which Aegon’s share of employees in joint ventures and associates |
545 | - | - | - | 33 | 6,780 | 141 | - | 7,499 |
Summarized assets and liabilities per segment |
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||||||
Cash and Cash equivalents |
548 | 8,382 | 317 | 67 | 116 | 71 | 141 | 1,125 | - | 10,768 | ||||||||||||||||||||||||||||||
Assets held for sale |
- | - | 5,249 | - | - | - | - | - | - | 5,249 | ||||||||||||||||||||||||||||||
Investments |
73,469 | 53,975 | 2,011 | 1,055 | 720 | 5,326 | 157 | 91 | - | 136,804 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
102,964 | 26,697 | 62,961 | 1,343 | 105 | - | - | - | (6 | ) | 194,063 | |||||||||||||||||||||||||||||
Investments in joint ventures |
6 | 1,008 | - | - | 480 | 118 | 99 | 1 | - | 1,712 | ||||||||||||||||||||||||||||||
Investments in associates |
77 | 74 | 7 | 6 | - | 14 | 122 | 8 | - | 308 | ||||||||||||||||||||||||||||||
Deferred expenses |
8,552 | 76 | 945 | 70 | 1 | 490 | - | - | - | 10,135 | ||||||||||||||||||||||||||||||
Other assets |
26,628 | 6,763 | 1,840 | 245 | 72 | 1,786 | 101 | 28,427 | (28,979 | ) | 36,883 | |||||||||||||||||||||||||||||
Total assets |
212,245 | 96,975 | 73,331 | 2,787 | 1,494 | 7,805 | 620 | 29,651 | (28,985 | ) | 395,923 | |||||||||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||||||||||||||||||
Insurance contracts |
68,556 | 34,379 | 1,451 | 624 | 703 | 6,696 | - | 24 | (1,615 | ) | 110,818 | |||||||||||||||||||||||||||||
Insurance contracts for account of policyholders |
72,501 | 25,587 | 22,862 | 1,109 | 108 | - | - | - | - | 122,168 | ||||||||||||||||||||||||||||||
Investment contracts |
6,824 | 9,787 | 278 | 52 | - | 2 | - | - | - | 16,943 | ||||||||||||||||||||||||||||||
Investment contracts for account of policyholders |
30,463 | 3,255 | 40,482 | 234 | - | - | - | - | - | 74,434 | ||||||||||||||||||||||||||||||
Liabilities held for sale |
- | - | 5,003 | - | - | - | - | - | - | 5,003 | ||||||||||||||||||||||||||||||
Other liabilities |
19,145 | 17,400 | 1,103 | 365 | 250 | 133 | 218 | 5,526 | (1,684 | ) | 42,456 | |||||||||||||||||||||||||||||
Total liabilities |
197,490 | 90,408 | 71,178 | 2,385 | 1,061 | 6,830 | 218 | 5,550 | (3,299 | ) | 371,821 |
Summarized assets and liabilities per segment |
LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | LOGO | ||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||||||
Cash and Cash equivalents |
928 | 7,410 | 1,010 | 47 | 92 | 271 | 183 | 1,407 | - | 11,347 | ||||||||||||||||||||||||||||||
Assets held for sale |
- | - | 8,705 | - | - | - | - | - | - | 8,705 | ||||||||||||||||||||||||||||||
Investments |
93,046 | 53,788 | 2,236 | 983 | 747 | 5,328 | 90 | 85 | - | 156,303 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
107,341 | 27,985 | 66,786 | 1,418 | 88 | - | - | - | (7 | ) | 203,610 | |||||||||||||||||||||||||||||
Investments in joint ventures |
7 | 877 | - | - | 495 | 134 | 99 | - | - | 1,614 | ||||||||||||||||||||||||||||||
Investments in associates |
95 | 21 | 8 | 2 | - | 21 | 125 | (1 | ) | - | 270 | |||||||||||||||||||||||||||||
Deferred expenses |
9,351 | 84 | 1,084 | 71 | 1 | 832 | - | - | - | 11,423 | ||||||||||||||||||||||||||||||
Other assets |
20,725 | 7,766 | 1,920 | 174 | 77 | 2,018 | 109 | 29,308 | (29,946 | ) | 32,152 | |||||||||||||||||||||||||||||
Total assets |
231,493 | 97,931 | 81,747 | 2,696 | 1,500 | 8,604 | 607 | 30,800 | (29,952 | ) | 425,425 | |||||||||||||||||||||||||||||
Liabilities |
||||||||||||||||||||||||||||||||||||||||
Insurance contracts |
75,942 | 34,900 | 1,747 | 558 | 722 | 7,466 | - | 20 | (1,785 | ) | 119,569 | |||||||||||||||||||||||||||||
Insurance contracts for account of policyholders |
75,328 | 26,275 | 18,112 | 1,126 | 89 | - | - | - | - | 120,929 | ||||||||||||||||||||||||||||||
Investment contracts |
10,148 | 9,043 | 355 | 24 | - | 2 | - | - | - | 19,572 | ||||||||||||||||||||||||||||||
Investment contracts for account of policyholders |
32,013 | 3,160 | 49,309 | 292 | - | - | - | - | - | 84,774 | ||||||||||||||||||||||||||||||
Liabilities held for sale |
- | - | 8,816 | - | - | - | - | - | - | 8,816 | ||||||||||||||||||||||||||||||
Other liabilities |
21,837 | 19,445 | 1,249 | 318 | 238 | (78 | ) | 180 | 6,438 | (2,203 | ) | 47,424 | ||||||||||||||||||||||||||||
Total liabilities |
215,268 | 92,822 | 79,586 | 2,318 | 1,049 | 7,390 | 180 | 6,458 | (3,988 | ) | 401,084 |
Investments |
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
||||||||||||||||||||||||||||||
2017 |
||||||||||||||||||||||||||||||||||||||||
Shares |
567 | 859 | 5 | 54 | 5 | 1 | 2 | 57 | - | 1,551 | ||||||||||||||||||||||||||||||
Debt securities |
54,535 | 21,411 | 1,779 | 712 | 646 | 5,252 | 9 | - | - | 84,344 | ||||||||||||||||||||||||||||||
Loans |
8,831 | 30,189 | - | 275 | 54 | 6 | - | 13 | - | 39,368 | ||||||||||||||||||||||||||||||
Other financial assets |
8,904 | 21 | 228 | 10 | - | 67 | 146 | 20 | - | 9,395 | ||||||||||||||||||||||||||||||
Investments in real estate |
633 | 1,495 | - | 4 | 15 | - | - | - | - | 2,147 | ||||||||||||||||||||||||||||||
Investments general account |
73,469 | 53,975 | 2,011 | 1,055 | 720 | 5,326 | 157 | 91 | - | 136,804 | ||||||||||||||||||||||||||||||
Shares |
- | 9,262 | 15,856 | 244 | 14 | - | - | - | (6 | ) | 25,370 | |||||||||||||||||||||||||||||
Debt securities |
3,116 | 13,370 | 8,125 | 216 | 9 | - | - | - | - | 24,836 | ||||||||||||||||||||||||||||||
Unconsolidated investment funds |
99,426 | 276 | 33,476 | 873 | 81 | - | - | - | - | 134,132 | ||||||||||||||||||||||||||||||
Other financial assets |
422 | 3,788 | 4,850 | 11 | 1 | - | - | - | - | 9,072 | ||||||||||||||||||||||||||||||
Investments in real estate |
- | - | 655 | - | - | - | - | - | - | 655 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
102,964 | 26,697 | 62,961 | 1,343 | 105 | - | - | - | (6 | ) | 194,063 | |||||||||||||||||||||||||||||
Investments on balance sheet |
176,434 | 80,672 | 64,972 | 2,398 | 825 | 5,326 | 157 | 91 | (6 | ) | 330,868 | |||||||||||||||||||||||||||||
Off-balance sheet investments third parties |
212,736 | 1,759 | 114,906 | 5,709 | 528 | 2,718 | 143,923 | - | (981 | ) | 481,297 | |||||||||||||||||||||||||||||
Total revenue-generating investments |
389,170 | 82,431 | 179,878 | 8,107 | 1,353 | 8,043 | 144,079 | 91 | (987 | ) | 812,165 | |||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||||||||||||||
Available-for-sale |
59,459 | 19,841 | 2,007 | 756 | 651 | 5,299 | 137 | 20 | - | 88,170 | ||||||||||||||||||||||||||||||
Loans |
8,831 | 30,189 | - | 275 | 54 | 6 | - | 13 | - | 39,368 | ||||||||||||||||||||||||||||||
Financial assets at fair value through profit or loss |
107,511 | 29,147 | 62,310 | 1,363 | 105 | 21 | 20 | 57 | (6 | ) | 200,528 | |||||||||||||||||||||||||||||
Investments in real estate |
633 | 1,495 | 655 | 4 | 15 | - | - | - | - | 2,801 | ||||||||||||||||||||||||||||||
Total investments on balance sheet |
176,434 | 80,672 | 64,972 | 2,398 | 825 | 5,326 | 157 | 91 | (6 | ) | 330,868 | |||||||||||||||||||||||||||||
Investments in joint ventures |
6 | 1,008 | - | - | 480 | 118 | 99 | 1 | - | 1,712 | ||||||||||||||||||||||||||||||
Investments in associates |
77 | 74 | 7 | 6 | - | 14 | 122 | 8 | - | 308 | ||||||||||||||||||||||||||||||
Other assets |
35,728 | 15,221 | 8,352 | 383 | 189 | 2,347 | 242 | 29,552 | (28,979 | ) | 63,034 | |||||||||||||||||||||||||||||
Consolidated total assets |
212,245 | 96,975 | 73,331 | 2,787 | 1,494 | 7,805 | 620 | 29,651 | (28,985 | ) | 395,923 |
Investments |
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
LOGO
|
||||||||||||||||||||||||||||||
2016 |
||||||||||||||||||||||||||||||||||||||||
Shares |
793 | 334 | 84 | 35 | 4 | - | 2 | 62 | - | 1,314 | ||||||||||||||||||||||||||||||
Debt securities |
70,766 | 23,741 | 2,036 | 633 | 683 | 5,310 | - | - | - | 103,169 | ||||||||||||||||||||||||||||||
Loans |
10,820 | 28,117 | - | 303 | 45 | 18 | - | - | - | 39,303 | ||||||||||||||||||||||||||||||
Other financial assets |
9,924 | 358 | 115 | 10 | - | - | 88 | 23 | - | 10,519 | ||||||||||||||||||||||||||||||
Investments in real estate |
743 | 1,238 | - | 3 | 15 | - | - | - | - | 1,999 | ||||||||||||||||||||||||||||||
Investments general account |
93,046 | 53,788 | 2,236 | 983 | 747 | 5,328 | 90 | 85 | - | 156,303 | ||||||||||||||||||||||||||||||
Shares |
- | 9,689 | 15,503 | 295 | 13 | - | - | - | (7 | ) | 25,492 | |||||||||||||||||||||||||||||
Debt securities |
4,779 | 15,434 | 9,847 | 235 | 10 | - | - | - | - | 30,305 | ||||||||||||||||||||||||||||||
Unconsolidated investment funds |
102,534 | - | 36,600 | 879 | 64 | - | - | - | - | 140,077 | ||||||||||||||||||||||||||||||
Other financial assets |
27 | 2,862 | 4,150 | 9 | 1 | - | - | - | - | 7,049 | ||||||||||||||||||||||||||||||
Investments in real estate |
- | - | 686 | - | - | - | - | - | - | 686 | ||||||||||||||||||||||||||||||
Investments for account of policyholders |
107,341 | 27,985 | 66,786 | 1,418 | 88 | - | - | - | (7 | ) | 203,610 | |||||||||||||||||||||||||||||
Investments on balance sheet |
200,387 | 81,774 | 69,021 | 2,401 | 834 | 5,328 | 90 | 85 | (7 | ) | 359,914 | |||||||||||||||||||||||||||||
Off-balance sheet investments third parties |
240,072 | 952 | 5,333 | 3,154 | 507 | 2,734 | 130,889 | - | (864 | ) | 382,776 | |||||||||||||||||||||||||||||
Total revenue-generating investments |
440,458 | 82,725 | 74,354 | 5,556 | 1,342 | 8,061 | 130,979 | 85 | (871 | ) | 742,690 | |||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||||||||||||||
Available-for-sale |
77,918 | 23,044 | 2,152 | 660 | 687 | 5,289 | 87 | 23 | - | 109,860 | ||||||||||||||||||||||||||||||
Loans |
10,820 | 28,117 | - | 303 | 45 | 18 | - | - | - | 39,303 | ||||||||||||||||||||||||||||||
Financial assets at fair value through profit or loss |
110,906 | 29,374 | 66,183 | 1,436 | 88 | 21 | 4 | 62 | (7 | ) | 208,066 | |||||||||||||||||||||||||||||
Investments in real estate |
743 | 1,238 | 686 | 3 | 15 | - | - | - | - | 2,685 | ||||||||||||||||||||||||||||||
Total investments on balance sheet |
200,387 | 81,774 | 69,021 | 2,401 | 834 | 5,328 | 90 | 85 | (7 | ) | 359,914 | |||||||||||||||||||||||||||||
Investments in joint ventures |
7 | 877 | - | - | 495 | 134 | 99 | - | - | 1,614 | ||||||||||||||||||||||||||||||
Investments in associates |
95 | 21 | 8 | 2 | - | 21 | 125 | (1 | ) | - | 270 | |||||||||||||||||||||||||||||
Other assets |
31,003 | 15,260 | 12,718 | 293 | 170 | 3,122 | 293 | 30,715 | (29,946 | ) | 63,627 | |||||||||||||||||||||||||||||
Consolidated total assets |
231,493 | 97,931 | 81,747 | 2,696 | 1,500 | 8,604 | 607 | 30,800 | (29,952 | ) | 425,425 |